Devo Manc

Views & Analysis

The NHS is moving rapidly towards integrated care models – and outcomes-based deals with pharma will also play a role.

Views & Analysis

Trailblazing ‘Accountable Care Systems’ announced in England to integrate health and social care.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.